Breast Lesion Localization Methods Market To Reach $1.57 Billion By 2025: Grand View Research, Inc.
The global breast lesion localization methods market is
expected to reach USD 1.57 billion by 2025, according to a new report by Grand
View Research, Inc. The increasing government and non-government reimbursement
policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations,
and other treatment options is estimated to increase the adoption of breast
lesion localization procedures. For instance, the Alabama Breast and Cervical
Cancer Early Detection Program aims to provide breast and cervical oncology
diagnostic and screening services to women who meet certain income, age, and
insurance coverage eligibility guidelines.
Furthermore, rising prevalence of
breast cancer is anticipated to propel the market growth. The disease is highly
prevalent amongst women belonging to the age group of 65 years or above. The
maximum risk of mammary gland cancer is between the age of 70 and 79. On the
other hand, men are also at a risk of breast cancer. In the U.S., median age of
men at diagnosis is approximately 68 years.
U.S. breast lesion
localization methods, by type, 2014 - 2025 (USD Billion)
Browse full research report on
Breast Lesion Localization Methods Market
Further key findings from
the report suggest:
- Wire
localization biopsy dominated the market in 2016 owing to its higher usage
by healthcare practitioners, easy availability, and presence of a wide
product range
- Magnetic
tracer is expected to grow at lucrative CAGR of 14.0% over the forecast
period as a result of increasing adoption of MagSNOLL technology over
conventional wire localization.
- Radioisotope
seed localization is considered the most preferred method amongst all
radioisotope localization methods due to its benefits such as ease of
localization few weeks before the excision surgery and lesser need for
reoperation.
- North America
is estimated to be the largest regional market. It dominated the market in
terms of revenue with USD 185.04 million in 2016 owing to the presence of
well-established healthcare services and increasing number of oncology
surgeries being performed.
- In addition,
early adoption of devices and shift from traditional to technologically advanced
products by healthcare providers are some of the factors anticipated to
increase the demand for localization devices in this region
- Asia Pacific
is expected to be the fastest growing region over the next decade with
lucrative CAGR from 2017 to 2025 due to growing awareness about breast
screening among the people. Furthermore, presence of a large target
population and rising disposable income are some of the factors expected
to propel the growth of this region.
- Key players
in this industry are Cianna Medical, Inc.; Cook Medical; STERYLAB; CP
Medical; SOMATEX Medical Technologies; Argon Medical Devices, Inc.; and
C.R BARD, Inc.
- Most of the
key players are focusing on strategies such as expansion of their product
portfolios and collaborations, mergers, & acquisitions. In November
2015, C.R. BARD, Inc. announced the acquisition of Liberator Medical
Holdings, Inc., a direct-to-customer distributor of medical products
For
more information: http://www.grandviewresearch.com
Comments
Post a Comment